Antigen‐specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapySander Kelderman, Nina Schumacher, Mireille Toebes et al.|European Journal of Immunology|2016Cited by 41
Properties of CD8 T-cell-recognized neoantigens in different tumor typesSteven L. C. Ketelaars, John B.A.G. Haanen, Marit M. van Buuren et al.|Immuno-Oncology Technology|2025Cited by 2